U Peters, T U Hausamen, F Grosse-Brockhoff. Show Affiliations »
Abstract
Entities: Chemical
Mesh: See more » Administration, OralAdultAntitubercular Agents/administration & dosageAntitubercular Agents/therapeutic useDigitoxin/administration & dosageDigitoxin/bloodDigitoxin/metabolismDrug Therapy, CombinationEthambutol/administration & dosageHumansHydroxylationIntestinal AbsorptionIsoniazid/administration & dosageKidney Tubules/metabolismKineticsLiver/metabolismMiddle AgedProtein BindingRadioimmunoassayRifampin/administration & dosageTuberculosis/drug therapy
Substances: See more » Antitubercular AgentsEthambutolDigitoxinIsoniazidRifampin
Year: 1974 PMID: 4426257 DOI: 10.1055/s-0028-1108142
Source DB: PubMed Journal: Dtsch Med Wochenschr ISSN: 0012-0472 Impact factor: 0.628